-
Description
Neisseria Meningitidis Vaccine 0.5 mL Vial
The Neisseria Meningitidis Vaccine is designed for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. This vaccine is suitable for individuals aged 2 months to 55 years and is administered intramuscularly.
Key Features
- Active immunization against meningococcal disease
- Effective for serogroups A, C, Y, and W-135
- Intramuscular injection
Version/Model
- Single-Dose Vial
Technical Specifications
- Volume 0.5 mL
- Storage Requires refrigeration
Application or Use Case
- Recommended for individuals aged 2 months to 55 years
Typical User/Industry Profile
- Healthcare providers and patients requiring meningococcal vaccination
About the Brand
GSK Menveo is a trusted brand in the field of vaccines, known for its innovative approach to preventing meningococcal disease. The brand is committed to providing effective immunization solutions to protect individuals from serious bacterial infections.
You May Also Like
